Wassim Mourtada

196 196 The GCC Club

Wassim Mourtada is the founder and CEO of QuanticAsset, a venture capital-backed firm focused on R&D in deep-tech artificial intelligence driven investment management. QuanticAsset develops and launches proprietary, institutional-grade hedge funds based on its AdaptiveOS technology. Together with its technology partners, QuanticAsset has raised and invested over $20 million in the development of the proprietary AdaptiveOS.

In 2002, Wassim founded his first artificial intelligence company, Genetics Squared, which applied proprietary approaches of AI to the field of personalized genetic medicine. Genetics Squared successfully created one of the first AI-based diagnostics in the field of cancer.

Wassim is also the founder of CrystalPoint Partners, a specialized principal investment firm focused on research commercialization. In that capacity, he has led the commercialization of technology platforms in diverse areas, such as Regenerative Medicine, Longevity, Synthetic Biology, and Hydrogen, among others.

Wassim was invited to partner with a prominent Abu Dhabi-based sovereign wealth fund, where he led the development of a US$6 billion initiative in the life sciences. He also assisted one of the leading Silicon Valley venture capital firms in raising US$100 million from another Abu Dhabi-based sovereign wealth fund at the peak of the 2008 financial crisis.

Previously, Wassim Mourtada served as the Associate Director of the University of Michigan’s Center for Venture Capital and Private Equity Finance, a not-for-profit think tank and research group serving venture capital & private equity firms, institutional investors, corporations, governments, managers, and entrepreneurs. Some of his research has been published by the US Federal Reserve Bank, the Government of France’s Conseil du Credit et du Titre, and the Financial Management Association, and has been cited in US Senate testimony.

His focus on research commercialization and technology transfer is internationally recognized. He served as the Chairman of the Advisory Board of the Inaugural Research Commercialization Conference, held in Boston in 2003, and is a major contributor to the notable publication “Taking Research to Market: How to Build and Invest in Successful University Spinouts,” published by Euromoney in 2004.

Wassim Mourtada was born in Beirut, Lebanon in 1974, raised in Abu Dhabi, and holds degrees in both Economics and Engineering from the University of Michigan in Ann Arbor.